Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial

Diabetic kidney disease (DKD) is the leading cause of ESRD. We conducted an open-label, prospective, randomized trial to determine whether pentoxifylline (PTF), which reduces albuminuria, in addition to renin-angiotensin system (RAS) blockade, can slow progression of renal disease in patients with t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Soc Nephrol
Autori principali: Navarro-González, Juan F., Mora-Fernández, Carmen, Muros de Fuentes, Mercedes, Chahin, Jesús, Méndez, María L., Gallego, Eduardo, Macía, Manuel, del Castillo, Nieves, Rivero, Antonio, Getino, María A., García, Patricia, Jarque, Ana, García, Javier
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Nephrology 2015
Soggetti:
Clinical Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4279740/
https://ncbi.nlm.nih.gov/pubmed/24970885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014010012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi